search results for

refine results

sort by


result type


Press Releases

Asia markets look flat, with traders on the sidelines ahead of Yellen speech

Asia markets are set to open flat, after most local markets remained near-unchanged this week ahead of a speech by the Fed chair.


Asia markets mixed; dollar edges higher while oil reverses morning losses

Asian stocks were mixed Thursday, with traders on the sidelines ahead of Janet Yellen's Friday speech, as Chinese markets fell on liquidity concerns.


What’s stopping luxury goods groups in China moving from bricks to clicks?

China’s luxury consumers are moving beyond bricks and mortar and going online for their next python-skin handbag fix, and high-end fashion retailers will have to follow them, analysts warn.


How to make money as a social media 'micro-influencer'

Marketers are now turning to "micro-influencers" and you could cash in so long as you have a social media account.


Blocking Ausgrid sale the 'correct decision', Ex-Aussie Deputy PM Swan says

Canberra’s rejection of the sale of Ausgrid to a Chinese consortium was the “correct decision” on grounds of national interests, former Aussie DPM Swan said.


How can social media empower musicians?

The String Social violinists Min Lee, Chloe Trevor, Drew Alexander Forde tell CNBC how they gained a large following on Instagram.


Australian treasurer Scott Morrison under attack for tax remarks

Australian treasurer Scott Morrison has come under fire for comments that unemployed citizens and those on welfare represented the "taxed nots" of society.


PayPal launches Fintech innovation lab in Singapore

PayPal's Rohan Mahadevan says that the firm has partnered with food and beverage players to help increase their efficiency through Fintech.


Fed is likely to stay dovish: Citibank Singapore

Citibank Singapore's Zal Devitre expects the Fed to extend its dovish stance and only hike in December, unless Yellen changes her tune at Jackson Hole.


Mylan was being opportunistic: Frost & Sullivan

Regulators should consider how to intervene when there is just one supplier for a specific drug, says Frost & Sullivan's Rhenu Bhuller.